Researchers systematically reviewed literature to understand the performance and sensitivity of alternative sample types compared with that of nasopharyngeal swabs for the diagnosis of SARS-CoV-2.
Researchers conducted a cross-sectional study among HCP at 4 large health care systems in 3 US states to assess the risk factors associated with SARS-CoV-2 seropositivity.
Study authors assessed the economic trade-offs of expanding and accelerating testing for SARS-CoV-2 across the United States in different transmission scenarios.
Study authors assessed the diagnostic accuracy of saliva NAAT for COVID-19 due to the increased resources, such as trained personnel, required for nasopharyngeal swab NAAT.
The COVID-19 Reporting and Data System (CO-RADS) in combination with a CT severity score are easy to use diagnostic tools to guide clinicians in diagnosing COVID-19.
Investigators summarized the evidence on the efficacy and adverse effects of antifungal agents in patients with hematological disease or undergoing hematopoietic stem cell transplantation.
Researchers compared a novel reverse transcription loop-mediated isothermal amplification method to the gold standard, reverse transcription polymerase chain reaction, and assessed the accuracy in detecting SARS-CoV-2.
In hospitalized patients with COVID-19, the routine use of molecular point-of-care testing in emergency department admissions was associated with a large reduction in time to results compared with laboratory PCR testing.
Study authors assessed the specificity and positive predictive value of a customized, institutional, early warning score for predicting decompensation in COVID-19 patients.
In settings where acid-fast bacilli pulmonary diseases are suspected, gastric aspirate culture may be helpful for diagnosing Mycobacterium avium complex and M kansasii pulmonary disease.
Researchers compared 3 immunochromatographic assays (Sienna™, Wondfo®, and Prometheus™) to detect antibodies against SARS-CoV-2 in serum samples, using RT-qPCR as a reference.
There is a low incidence of second PJI in patients with bacteremia or hematogenous periprosthetic joint infection with concomitant prosthetic implants.